James Boylan is an accomplished health care executive, entrepreneur, and innovator with three decades of experience in mergers and acquisitions. Currently, they serve as the CEO of Enavate Sciences and a Senior Advisor at Patient Square Capital. James has held leadership roles, including President and Head of IBK at SVB Leerink, and has contributed to various organizations as a Board Member. They earned an MBA in Finance from Columbia Business School and a BS in Finance from Lehigh University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices